Iofina plc (IF7) Q2 2026 Earnings Report

The call was strongly positive, with record first-half operating and financial performance, a 29% increase in iodine production, sharply improved gross profit and EBITDA, positive cash generation, strong customer demand, and multiple plants advancing toward the pathway to 2,000 metric tons. The main challenges were rising chemical costs, regulatory delays at IO#12, a deferred delivery, limited specificity on IO#13 and IO#14 tonnage, and the continued prioritization of reinvestment over dividends. Highlights significantly outweighed the lowlights.

IO#12 is expected to be moving water through the facility in the next few weeks and ramp up in production shortly thereafter, with capacity for about 50,000 bpd of water and plant capital costs expected to come in right around $8.8 million; IO#11 is expected to increase from a 100 metric ton plant to somewhere between 145 and 160 metric tons of production; IO#13 and IO#14 are anticipated to come online in the first half of next year, with total volume likely to be higher than the average amounts of plants in Oklahoma, which are somewhere between 100 and 150 metric ton of plants on average; production capacity is expected to exceed 1,000 metric tons once IO#12 comes online, with a pathway to 2,000 metric tons; the company is on track to meet market expectations in fiscal year 2026, expects increases in iodine production all the time, and said profitability should increase at the same time as long as it can control costs and the iodine market continues to expand; it has sales in hand for all of the projected production planned to be sold into the open market throughout the rest of the year and expects to start selling iodine or taking purchase orders for iodine into 2027 shortly.